Drugs Flashcards

1
Q

Erythromycin and Clindamycin:

MOA, Clinical, Adverse Effects,

A

MOA: It is a 50S subunit inhibitor, and is a bacteriostatic and inhibits protein synthesis.

Bacteriostatic.

Clindamycin causes pseudomembranous colitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Benzoyl Peroxide

A

MOA: absorbed by skin –> benzoic acid –> metabolized by purine–> oxidize of bacterial proteins. Is

Clinical: acne rosacea.

Used in combo with antibiotics. Greater efficacy and decreased resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dapsone

MOA
Adverse Effects:

A

MOA: antibacterial and antibacterial

Adverse Effects: Methemoglobinemia and orange staining of skin benzoyl peroxide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Azelaic Acid

MOA, Clinical Uses

A

MOA: anti comedome, anti-hyperproliferation, competitive inhibitor of mitochondrial oxidoreducatases and 5 alpha reductase, which lowers hyperpigmentation.

Clinical: Lightens post inflammatory hyperpigmentation, mild inflammatory acne, and comedonal acne.

Adverse Effects: Hypo-pigmentaton of the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Doxyxlycline, Minocycline, Tetracycline

MOA, Clinical Uses

A

MOA: 16rRNA of the 30s subunit, preventing binding of aminoacyl tRNA to the acceptor site

Clinical Uses: for inflammatory acne vulgaris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clotrimazole and Miconazole.
MOA:
Adverse Effects:

A

MOA: Inhibit CYP450 14 alpha- demethylase (essential enzyme in ergosterol synthesis)

Clinical: Tinea Corporis, Tinea Cruris, tinea pedis, tine versicolor, Tina nigra.

Miconazole: is used for diaper dermatitis complicated by Candida albicans infection.

Adverse Effects: irritation, burning/ stinging,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ketaconazole:

MOA:

Clinical Uses: (Topical)

Adverse Effects (oral)

Contraindications:

Do not use:

A

MOA: same as all azoles

Shampoo/ foam: seborrheic dermatitis, white and black piedra.

Clinical Uses:

Shampoo: Seborrheic Dermatitis

Topical: Tinea pedis, Tinea Cruris, Tinea Corporis

Clinical oral: chromomycosis, paracoccidioidimycosis, mucocutaneous candidiadis.

Do not use: if patient has achrohydria, is on bicarb, antacids, H2-blockers or PPIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Itraconazole and Fluconazole
MOA
Clinical Aspects

A

MOA: CYP-450 14 alpha Demethylase needed for ergosterol synthesis.

Clinical Aspects: Used for onychomycosis.

Itraconzole: white pierdra, lobo mycosis, chromoblastomycosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Terbinafine:

MOA
Clinical Use:
Oral Use:
Topical:

Side Effects:

A

MOA: It affects squalene epoxidase–> stops ergosterol synthesis

Clinical: first line for the dermatophytosis

Topical: tinea corporis, curries, versicolor and nigra

Oral: First choice for onychomycosis

Side Effects: Are change or loss of taste and smell. Not recommended in patients with renal or hepatic failure or in pregnant women.

Not recommended for renal or hepatic failure in women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Naftinine:
MOA:
Clinical:
Adverse Effects:

A

MOA: same as any oral allylamine.
Clinical: tinea, corporis, pedis, curries.
Anti-inflammatory activity.
Adverse Effects:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Butenafine:

MOA:
Clinical
Adverse Effects

A

works as general allylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Griseolfulvin:
MOA:
Clinical:
Contraindications:

A

MOA: inhibition of mitotic spindle and inhibition of fungal mitosis

Clinical: Tinea Capitis , fungistatic and requires long time to be useful

Contraindications: pregnancy, patients with poryphria and hepatic failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ciclopirox Olamine

A

MOA: chelation of polyvalent cations resulting in stopping of metal dependent enzymes that are responsible for degradation of peroxides within fungal cell.

Clinical: Mild to moderate onychomycosis of fingernails and toenails. Seborrheic dermatitis, white piedra.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Imiquimod:
MOA:
Clinical:
Adverse Effects:

A

MOA: TLR7 agonist for immune cells and induces production of interferons alpha and gamma

Clinical: genital and perianal warts, common warts and cutaneous warts

Molluscum contagium

HSV off label.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cimetidine:

MOA
Clinical
Adverse Effects:

A

MOA: immunoomdulatory effects by histamine induced T suppressor cell activity.

Clinical: warts in children, and molluscum contagious in small children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lindane:
MOA:
Clinical Use
Contraindications:

A

MOA: It is directly absorbed by the parasites and ova through exoskeleton.

It activates the nervous system–> causes seizures and death of parasitic arthropods.

Clinical: scabies and lice.

Contra: potential for neurotoxicity and hematoxivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Crotamiton:
MOA:

A

MOA: scabicidal activity, and antipruritic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Permethrin:

MOA:
Clinical:

A

MOA: inhibits sodium ion channel through sodium ion cell membranes channels. Paralysis and death of the parasite.

Clinical: head lice and nits (lotion and cream), and scabies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ivermectin:

MOA:
Clinical:

A
  1. Glutamate gated chloride channel binding–> increases cl ions, and hyperpolarization of nerve of muscle cell and death of parasite

Clinical: topical heals lice and rosacea in adults, and immature onchocerciasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Praziquantel

MOA:
Clinical:

A

MOA: increases cell permeability to schistosomes, and causes there to be strong contractions and paralysis of worm musculature.

Clinical: Schistosoma adult forms

`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Glucocorticoids

MOA:
Clinical Uses:

A

MOA: anti-inflammatory and immunosuppressive effects. Used for inflammatory and pruritic conditions.

MOA: bind to glucocorticoid response elements in DNA.

Adverse Effects: Tachyphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hydrocortisone

Clinical:

A

Clinical: corticoid responsive dermatoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Betamethasone

A

Clinical: corticoid responsive dermatoses, plaque psoriasis

24
Q

Halobetasol

A

Clinical: corticosteroid responsive dermatoses, plaque psoriasis

25
Q

Clobetasol

A

Clinical: Corticosteroid responsive dermatoses, psoriasis.

Adverse: growth retardations

26
Q

Adapalene
MOA:
Clinical:
Adverse Effects:

A

MOA: binds to RAR. Comedolytic, normalize desquamation.

Clinical: bactericidal with activity abasing P. Acnes

27
Q

Tretinoin:

A

MOA: comedlytic, normalize desquamation

28
Q

Tazarotene:

A

MOA: prodrug hydrolyzed to tazoretinic acid. Binds to RAR. Anti-inflammatory, anti proliferative and immunological activity.

Clinical: acne vulgaris, psoriasis, facial mottled hyper and hypopigmentation, and benign facial lentigenes.

Pregnancy Category X

29
Q

Isotretinoin

A

MOA: Decreased sebum, C.acnes concentration and inflammation. Strong comedolytic effects,

Teratogen, patients f childbearing age must be on 2 forms of contraception and monthly pregnancy checks should be done.

30
Q

How do antihistamines work?

A

Sedating and used for nighttime itch.

Non-sedating H1 receptor and H2 receptor have almost limited effect in treatment of chronic itch.

Elderly population: may be confusion and urinary retention.

31
Q

Diphenhydramine
MOA:
Clinical/ Adverse:

A

MOA: blocks the H1 receptor
Clinical: for chronic urticaria, nocturnal itch, and drug related itch

Contra: not for neonates, premature infants, and nursing mothers.

Note: topical products are not OTC for children under 2 yeas.

32
Q
Doxepin 
MOA: 
Clinical: 
Adverse Effects: 
Contraindications:
A

MOA: blocks H1 and H2 receptors
Clinical: nocturnal urticaria
Contraindication: QT prolonging.

33
Q

Hydroxyzine

A

MOA: it is basically a H1 receptor blocker.

Clinical: Histamine mediated pruritis, and pruritis due to allergic conditions

34
Q

Hydroquinone:
MOA:
Adverse Effects:

A

MOA: inhibits tyrosine kinase
Clinical: temporarily reduces hypo pigmentation

There is possible carcinogenicity

35
Q

Monobenzone

A

MOA: irreversible depigmentation
Clinical: for vitiligo patiens, some percutaneous absorption takes place.

36
Q

Mequinol

Contraindications:

A

MOA: Substrate for the enzyme tyrosinase, competitive inhibitor of formation of melanin precursor.

Clinical: solar lentigenes

Contraindications: mequinol and tretinoin can cause fetal harm

37
Q

Minoxidil

A

MOA: Stimulates hair growth secondary to vasodilation.

Androgenic Alopecia: reverses progressive miniaturization of terminal scalp hairs.

38
Q

Finasteride

A

MOA: 5 alpha reductase inhibitors –> blocks testosterone to DHT conversion.

Clinical: promotes hair growth and prevents further hair loss

39
Q

Bimatoprost

A

MOA: synthetic analog of prostaglandin

Clinical: hypertrophichosis of eyelashes.

40
Q

Acitretin

A

check the slide

41
Q

Calcipotriene

A

Synthetic Vitamin D3, binds to D3 receptors and inhibits keratinocyte proliferation

Clinical: Plaque type psoriasis vulgaris.

42
Q

Calcitriol

A

Better tolerated and used treat plaque psoriasis

43
Q

Etanercept

A

TNF receptor dimer that binds to both TNF alpha and TNF beta.

Decoy receptor not a monoclonal antibody.

44
Q

Infliximab

A

Partially humanized mouse antibody against TNF alpha

45
Q

Adalimumab

A

Fully human IgG1 antibody. that binds to TNF

Clinical: moderate to severe plaque psoriasis, psoriatic arthritis

46
Q

Certolizumab

A

binds selectively and neutralizes TNF alpha activity.

Does not induce complement activation, ab dependent cell mediated cytotoxicity or apoptosis.

Moderate to severe plaque psoriasis, psoriatic arthritis

47
Q

Ustekinumab

A

MOA: human Ig1K monoclonal antibody. Binds with high affinity and specificity to p40 subunit of IL-12 and IL-23

–> inhibits chemokine and cytokine release

used for moderate to severe plaque psoriasis

48
Q

Guselkumba, Tildrazkizumbab, Rizankizumab

A

IgI1 monoclonal antibody.

Binds to p-19 subunit of IL-23
same as ustekinumba.

49
Q

Secukinumab, Ixekizumab

A

binds to IL-17A, inhibits release of pro inflammatory cytokines and chemokine.

S–> IgG1
I–> IgG 4

50
Q

Brodalumab

A

Humanized Ig2 monoclonal antibody that binds selectively to IL-17A receptor

suicidal ideation and behavior.

51
Q

Ipilimumab

A

Ig1- Anti-CTLA-4 antibody that binds to CTLA 4 that down regulates the T cell activation.

Treats melanoma + metastatic to the brain

52
Q

Nivolumab and Pembrolizumab

A

Ig4-Anti-PD antibody to L1/L2

Melanoma and lymph nodes cancer

53
Q

Aldesleukin

A

IL-2–> increases WBC, lymphocyte toxicity, killer cell activity, IFN-gamma production.

Adverse: capillary leak syndrome

CI: only for patients with normal cardiac and pulmonary function

54
Q

Encororafenib

Cobimetinib

A

BRAF inhibitor and combined with +Binemetinib

+ Vermurafinib and reversible MAPK inhibitor

55
Q

Dabrafenib

A

+Trametinib
V600E +K
inhibits mutated BRAF including 600E

56
Q

Actinic Keratosis

A

Topical treatment for precancerous Actinic keratosis–> Diclofenac/ Doclifenyak